Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-label Clinical Trial.

ABSTRACT:

SUBMITTER: Dahlgren MK 

PROVIDER: S-EPMC9429743 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature